OI-3

N/A

Report date: 2025/09/10 10:58:20

Base Information

Drug NameOI-3

Drug Alias NameOI-3

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionImmunomodulatorsMelanoma cell adhesion molecule inhibitors

TargetsMelanoma cell adhesion molecule

Therapy Area/IndicationsOsteosarcoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOncoinvent As

China Registration ClassN/A

Develop Information

Active CompaniesOncoinvent As

Inactive CompaniesN/A

Active IndicationsOsteosarcoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A